Skip to content
10-K

Annual Report

Kezar Life Sciences, Inc.

0001628280-26-021737

← back to feed
Filed
Mar 27, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 23, 2026 7.37M sh
Shares Diluted FY 2025 · Dec 31, 2025 7.32M sh
Shares Diluted FY 2025 · Dec 31, 2024 7.29M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 7.26M sh
Dividends Paid FY 2025 · Dec 31, 2025 $0
Capex FY 2025 · Dec 31, 2025 $8K
Capex FY 2025 · Dec 31, 2024 $29K
Capex FY 2025 · Dec 31, 2023 $1.81M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$51.78M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$74.21M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$81.65M
Long Term Debt FY 2025 · Dec 31, 2025 $0
Long Term Debt FY 2025 · Dec 31, 2024 $5.11M
Short Term Debt FY 2025 · Dec 31, 2025 $0
Short Term Debt FY 2025 · Dec 31, 2024 $5.22M
Cash And Equivalents FY 2025 · Dec 31, 2025 $71.88M
Cash And Equivalents FY 2025 · Dec 31, 2024 $41.75M
Stockholders Equity FY 2025 · Dec 31, 2025 $70.07M
Stockholders Equity FY 2025 · Dec 31, 2024 $116.92M
Stockholders Equity FY 2025 · Dec 31, 2023 $187.57M
Stockholders Equity FY 2025 · Dec 31, 2022 $269.87M
Current Liabilities FY 2025 · Dec 31, 2025 $6.57M
Current Liabilities FY 2025 · Dec 31, 2024 $20.33M
Total Liabilities FY 2025 · Dec 31, 2025 $6.57M
Total Liabilities FY 2025 · Dec 31, 2024 $27.77M
Current Assets FY 2025 · Dec 31, 2025 $75.73M
Current Assets FY 2025 · Dec 31, 2024 $137.49M
Total Assets FY 2025 · Dec 31, 2025 $76.65M
Total Assets FY 2025 · Dec 31, 2024 $144.68M
Eps Diluted FY 2025 · Dec 31, 2025 −$7.66
Eps Diluted FY 2025 · Dec 31, 2024 −$11.49
Eps Diluted restated FY 2025 · Dec 31, 2023 −$14.04
Eps Basic FY 2025 · Dec 31, 2025 −$7.66
Eps Basic FY 2025 · Dec 31, 2024 −$11.49
Eps Basic restated FY 2025 · Dec 31, 2023 −$14.04
Sga Expense FY 2025 · Dec 31, 2025 $18.51M
Sga Expense FY 2025 · Dec 31, 2024 $23.39M
Sga Expense FY 2025 · Dec 31, 2023 $26.54M
Rd Expense FY 2025 · Dec 31, 2025 $33.76M
Rd Expense FY 2025 · Dec 31, 2024 $65.74M
Rd Expense FY 2025 · Dec 31, 2023 $85.7M
Net Income FY 2025 · Dec 31, 2025 −$56.03M
Net Income FY 2025 · Dec 31, 2024 −$83.74M
Net Income FY 2025 · Dec 31, 2023 −$101.87M
Operating Income FY 2025 · Dec 31, 2025 −$59.11M
Operating Income FY 2025 · Dec 31, 2024 −$90.61M
Operating Income FY 2025 · Dec 31, 2023 −$111.42M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $0
Revenue FY 2025 · Dec 31, 2023 $7M